These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31603197)

  • 1. Expand SNAP to Reduce Nonalcoholic Fatty Liver Disease in the United States.
    Gundersen C
    J Nutr; 2020 Jan; 150(1):6-7. PubMed ID: 31603197
    [No Abstract]   [Full Text] [Related]  

  • 2. Food Insecurity May Be an Independent Risk Factor Associated with Nonalcoholic Fatty Liver Disease among Low-Income Adults in the United States.
    Golovaty I; Tien PC; Price JC; Sheira L; Seligman H; Weiser SD
    J Nutr; 2020 Jan; 150(1):91-98. PubMed ID: 31504710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why we need to curb the emerging worldwide epidemic of nonalcoholic fatty liver disease.
    Diehl AM; Farpour-Lambert NJ; Zhao L; Tilg H
    Nat Metab; 2019 Nov; 1(11):1027-1029. PubMed ID: 32694863
    [No Abstract]   [Full Text] [Related]  

  • 4. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe.
    Younossi ZM; Blissett D; Blissett R; Henry L; Stepanova M; Younossi Y; Racila A; Hunt S; Beckerman R
    Hepatology; 2016 Nov; 64(5):1577-1586. PubMed ID: 27543837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China).
    Fan JG; Wei L; Zhuang H;
    J Dig Dis; 2019 Apr; 20(4):163-173. PubMed ID: 30444584
    [No Abstract]   [Full Text] [Related]  

  • 6. Integration of public health measures for NAFLD into India's national programme for NCDs.
    Sarin SK; Prasad M; Ramalingam A; Kapil U
    Lancet Gastroenterol Hepatol; 2021 Oct; 6(10):777-778. PubMed ID: 34509189
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
    Younossi ZM; Henry L; Bush H; Mishra A
    Clin Liver Dis; 2018 Feb; 22(1):1-10. PubMed ID: 29128049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease burden - Saudi Arabia and United Arab Emirates, 2017-2030.
    Alswat K; Aljumah AA; Sanai FM; Abaalkhail F; Alghamdi M; Al Hamoudi WK; Al Khathlan A; Al Quraishi H; Al Rifai A; Al Zaabi M; Babatin MA; Estes C; Hashim A; Razavi H
    Saudi J Gastroenterol; 2018; 24(4):211-219. PubMed ID: 29956688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for Nonalcoholic Fatty Liver Disease in Persons with Type 2 Diabetes in the United States Is Cost-effective: A Comprehensive Cost-Utility Analysis.
    Noureddin M; Jones C; Alkhouri N; Gomez EV; Dieterich DT; Rinella ME;
    Gastroenterology; 2020 Nov; 159(5):1985-1987.e4. PubMed ID: 32763241
    [No Abstract]   [Full Text] [Related]  

  • 10. [Strengthen researches on risk factors and early diagnosis of nonalcoholic fatty liver].
    Li YM
    Zhonghua Gan Zang Bing Za Zhi; 2013 Nov; 21(11):805-7. PubMed ID: 24516924
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter to the editor: Treating nonalcoholic fatty liver disease with statins. Are all statins equal?
    Athyros VG; Katsiki N; Mikhailidis DP
    Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G681-G682. PubMed ID: 28596414
    [No Abstract]   [Full Text] [Related]  

  • 12. Increasing Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease Among Hospitalized Adults in the United States.
    Hirode G; Vittinghoff E; Wong RJ
    J Clin Gastroenterol; 2019; 53(10):765-771. PubMed ID: 31135632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rising incidence of nonalcoholic fatty liver disease.
    Wisocky J; Paul S
    Nurse Pract; 2017 Jul; 42(7):14-20. PubMed ID: 28562448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease.
    Estes C; Razavi H; Loomba R; Younossi Z; Sanyal AJ
    Hepatology; 2018 Jan; 67(1):123-133. PubMed ID: 28802062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
    Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A
    World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NASH and liver cancer: the new cancer headline.
    Cryer D
    Am J Manag Care; 2019 Oct; 25(11 Spec No.):SP334-SP335. PubMed ID: 31860245
    [No Abstract]   [Full Text] [Related]  

  • 17. SNAP: The Most Important Component of Our Efforts to End Food Insecurity in the United States.
    Gundersen C
    Am J Public Health; 2022 Oct; 112(10):1370-1371. PubMed ID: 35981279
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of Supplemental Nutrition Assistance Program-Education (SNAP-Ed) on food security and dietary outcomes.
    Rivera RL; Maulding MK; Eicher-Miller HA
    Nutr Rev; 2019 Dec; 77(12):903-921. PubMed ID: 31077323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World.
    Sayiner M; Koenig A; Henry L; Younossi ZM
    Clin Liver Dis; 2016 May; 20(2):205-14. PubMed ID: 27063264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The increasing burden of nonalcoholic fatty liver disease among young adults in the United States: A growing epidemic.
    Mrad RA; Merjaneh N; Mubarak G; Lopez R; Zein NN; Alkhouri N
    Hepatology; 2016 Oct; 64(4):1386-7. PubMed ID: 26991537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.